Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2019-12-09 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
108年11月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative operating revenue figures for a company named 科妍, with data presented in a tabular format. It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document length is short (765 characters) and it does not contain detailed financial statements or comprehensive analysis. It appears to be a regulatory or public disclosure of revenue figures rather than a full financial report or earnings release. There is no indication that this is an earnings release (ER) since it lacks key highlights or narrative commentary. It is also not an annual or interim report, nor a management discussion. Given the nature and length, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2019-12-09 Chinese
108年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, providing information about fund lending balances and endorsement guarantees for the current and previous months, with zero amounts reported. The content is concise, factual, and relates to regulatory disclosure of financial guarantees and lending status. It does not contain detailed financial statements, management discussion, or report analysis. It is not an announcement of a meeting, voting results, or legal matters. Given the short length (601 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-12-09 Chinese
108年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider shareholding disclosures rather than financial results, management changes, or meeting materials. There is no indication of financial statements, earnings data, or meeting results. This type of document corresponds to notifications about insider share transactions or holdings by directors and executives. Therefore, the document fits the category of Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just an announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2019-12-06 Chinese
108年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors, supervisors, and managers. It lists their current holdings, pledged shares, and related percentages. The content focuses on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. This type of document corresponds to insider share transactions or holdings disclosures. Given the nature of the data, it fits best under the category 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives. The document length is under 5,000 characters and contains detailed insider shareholding data, not a report announcement or certification. Therefore, the classification is DIRS with high confidence.
2019-12-06 Chinese
108年11月25日內部人設質解質
Director's Dealing Classification · 100% confidence The document is a short tabular report showing a pledge of shares by a company director (董事長本人) with details on the number of shares pledged and the pledgee. It is a notification of a director's personal share transaction activity, specifically a pledge of shares. The document length is very short (319 characters), and the content matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. There is no indication of other report types such as financial results, management changes, or regulatory filings. Therefore, the classification is DIRS with high confidence.
2019-11-26 Chinese
108年11月法人說明會簡報 — 178620191122E001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Inventor Conference 2018' and contains detailed business, product, technology overview, and financial data including profit & loss, balance sheet, and cash flows for periods in 2018 and 2019. It includes forward-looking statements, market analysis, product descriptions, and consolidated financial statements. The length is substantial (13,491 characters) and contains actual financial data and analysis rather than just an announcement or summary. There is no indication that this is a certification, voting result, or a regulatory announcement. The content aligns with a comprehensive financial and business report for a period shorter than a full fiscal year (Jan-Sep 2019 and 2018), which fits the definition of an Interim / Quarterly Report (IR). 9M 2019
2019-11-22 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.